Literature DB >> 20112009

Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice.

Annika Thorsell1, Jesse R Schank, Erick Singley, Stephen P Hunt, Markus Heilig.   

Abstract

RATIONALE: Reduced voluntary alcohol consumption was recently found in neurokinin-1 receptor (NK1R)-deficient (KO) mice. It remains unknown whether this reflects developmental effects or direct regulation of alcohol consumption by NK1R:s, and whether the reduced consumption reflects motivational effects.
OBJECTIVE: The objective of this study is to obtain an expanded preclinical validation of NK1R antagonism as a candidate therapeutic mechanism in alcohol use disorders.
METHODS: The NK1R antagonist L-703,606 and NK1R KO mice were used in models that assess alcohol-related behaviors.
RESULTS: L-703,606 (3-10 mg/kg i.p.) dose-dependently suppressed alcohol intake in WT C57BL/6 mice under two-bottle free choice conditions but was ineffective in NK1R KO:s, demonstrating the receptor specificity of the effect. Alcohol reward, measured as conditioned place preference for alcohol, was reduced by NK1R receptor deletion in a gene dose-dependent manner. In a model where escalation of intake is induced by repeated cycles of deprivation and access, escalation was seen in WT mice, but not in KO mice. Among behavioral phenotypes previously reported for NK1R mice on a mixed background, an analgesic-like phenotype was maintained on the C57BL/6 background used here, while KO:s and WT:s did not differ in anxiety- and depression-related behaviors.
CONCLUSIONS: Acute blockade of NK1R:s mimics the effects of NKR1 gene deletion on alcohol consumption, supporting a direct rather than developmental role of the receptor in regulation of alcohol intake. Inactivation of NK1R:s critically modulates alcohol reward and escalation, two key characteristics of addiction. These data provide critical support for NK1R antagonism as a candidate mechanism for treatment of alcoholism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20112009     DOI: 10.1007/s00213-010-1775-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  52 in total

1.  Antinociceptive and pro-inflammatory roles for NPY Y(1) receptors.

Authors:  A Lecci
Journal:  Trends Pharmacol Sci       Date:  2001-05       Impact factor: 14.819

2.  Development of an alcohol deprivation and escalation effect in C57BL/6J mice.

Authors:  Roberto I Melendez; Lawrence D Middaugh; Peter W Kalivas
Journal:  Alcohol Clin Exp Res       Date:  2006-12       Impact factor: 3.455

Review 3.  Addiction and the brain antireward system.

Authors:  George F Koob; Michel Le Moal
Journal:  Annu Rev Psychol       Date:  2008       Impact factor: 24.137

4.  The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline.

Authors:  Luc Jasmin; Duc Tien; David Weinshenker; Richard D Palmiter; Paul G Green; Gabriella Janni; Peter T Ohara
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

6.  Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression.

Authors:  Mark S Kramer; Andrew Winokur; Jeffrey Kelsey; Sheldon H Preskorn; Anthony J Rothschild; Duane Snavely; Kalyan Ghosh; William A Ball; Scott A Reines; Dennis Munjack; Jeffrey T Apter; Lynn Cunningham; Mitchel Kling; Mohammed Bari; Albert Getson; Yih Lee
Journal:  Neuropsychopharmacology       Date:  2004-02       Impact factor: 7.853

7.  Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.

Authors:  David T George; Jodi Gilman; Jacqueline Hersh; Annika Thorsell; David Herion; Christopher Geyer; Xiaomei Peng; William Kielbasa; Robert Rawlings; John E Brandt; Donald R Gehlert; Johannes T Tauscher; Stephen P Hunt; Daniel Hommer; Markus Heilig
Journal:  Science       Date:  2008-02-14       Impact factor: 47.728

8.  Neurokinin-1 receptor antagonists modulate brain noradrenaline and serotonin interactions.

Authors:  Nasser Haddjeri; Pierre Blier
Journal:  Eur J Pharmacol       Date:  2008-10-09       Impact factor: 4.432

Review 9.  Neuronal pathways linking substance P to drug addiction and stress.

Authors:  K G Commons
Journal:  Brain Res       Date:  2009-11-11       Impact factor: 3.252

10.  Increased neurogenesis and brain-derived neurotrophic factor in neurokinin-1 receptor gene knockout mice.

Authors:  Sara Morcuende; Christopher A Gadd; Marco Peters; Andrew Moss; Elizabeth A Harris; Anne Sheasby; Amy S Fisher; Carmen De Felipe; Patrick W Mantyh; Nadia M J Rupniak; K Peter Giese; Stephen P Hunt
Journal:  Eur J Neurosci       Date:  2003-10       Impact factor: 3.386

View more
  35 in total

Review 1.  Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

Authors:  George R Breese; Rajita Sinha; Markus Heilig
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

Review 2.  The ventral pallidum and relapse in alcohol seeking.

Authors:  Asheeta A Prasad; Gavan P McNally
Journal:  Br J Pharmacol       Date:  2020-07-09       Impact factor: 8.739

3.  Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats.

Authors:  Lydia O Ayanwuyi; Serena Stopponi; Massimo Ubaldi; Andrea Cippitelli; Cinzia Nasuti; Ruslan Damadzic; Markus Heilig; Jesse Schank; Kejun Cheng; Kenner C Rice; Roberto Ciccocioppo
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

4.  The role of the neurokinin-1 receptor in stress-induced reinstatement of alcohol and cocaine seeking.

Authors:  Jesse R Schank; Courtney E King; Hui Sun; Kejun Cheng; Kenner C Rice; Markus Heilig; David Weinshenker; Jason P Schroeder
Journal:  Neuropsychopharmacology       Date:  2013-10-31       Impact factor: 7.853

Review 5.  Genes and Alcohol Consumption: Studies with Mutant Mice.

Authors:  J Mayfield; M A Arends; R A Harris; Y A Blednov
Journal:  Int Rev Neurobiol       Date:  2016       Impact factor: 3.230

Review 6.  Promising pharmacogenetic targets for treating alcohol use disorder: evidence from preclinical models.

Authors:  Jennifer A Rinker; Patrick J Mulholland
Journal:  Pharmacogenomics       Date:  2017-03-27       Impact factor: 2.533

Review 7.  Neurokinin receptors in drug and alcohol addiction.

Authors:  Jesse R Schank
Journal:  Brain Res       Date:  2020-02-15       Impact factor: 3.252

8.  Pharmacokinetics and central nervous system effects of the novel dual NK1 /NK3 receptor antagonist GSK1144814 in alcohol-intoxicated volunteers.

Authors:  Erik T te Beek; Justin L Hay; Jonathan N Bullman; Clare Burgess; Kimberly J Nahon; Erica S Klaassen; Frank A Gray; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

9.  A differential role for neuropeptides in acute and chronic adaptive responses to alcohol: behavioural and genetic analysis in Caenorhabditis elegans.

Authors:  Philippa Mitchell; Richard Mould; James Dillon; Steven Glautier; Ioannis Andrianakis; Christopher James; Amanda Pugh; Lindy Holden-Dye; Vincent O'Connor
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

10.  TACR1 genotypes predict fMRI response to alcohol cues and level of alcohol dependence.

Authors:  Sara Blaine; Eric Claus; Nicole Harlaar; Kent Hutchison
Journal:  Alcohol Clin Exp Res       Date:  2012-10-18       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.